1,412 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

56S1

Sartorius Stedim Biotech
€170.35-5.2%-22.8%€16.6b€213.93PE97.8xE30.3%0.4%

D8Y0

Sandoz Group
CHF 37.203.3%n/aCHF 15.1bCHF 40.50PS1.8xE33.8%1.2%

D8Y0

Sandoz Group
CHF 36.800.5%n/aCHF 15.1bCHF 40.07PS1.8xE33.8%1.2%

AVG

Avantor
US$22.80-6.6%16.6%US$17.7bUS$25.22PE48.8xE25.0%n/a

SRT

Sartorius
€196.405.8%-24.5%€15.8b€204.18PE224.2xE33.7%0.3%

SRT

Sartorius
€203.009.3%-23.1%€15.8b€211.04PE224.2xE33.7%0.3%

SRT0

Sartorius
€47.800.4%-22.3%€15.8b€49.69PE224.2xE33.7%0.3%

SRT4

Sartorius
€37.800.5%-23.2%€15.8b€39.30PE224.2xE33.7%0.3%

RPD

Royalty Pharma
US$24.991.7%0.4%US$16.7bUS$39.64PE18.8xE11.4%3.0%

3KY

Hansoh Pharmaceutical Group
HK$2.4610.8%93.7%HK$128.5bHK$2.64PE24.6xE2.4%1.9%

UTH

United Therapeutics
US$321.503.1%51.2%US$15.9bUS$319.69PE14.9xE6.8%n/a

PKN

Revvity
US$112.804.3%7.7%US$15.6bUS$119.79PE78.8xE25.8%0.2%

EII0

Eisai
JP¥54.170%n/aJP¥2.1tJP¥65.16PE78.6xE25.1%2.2%

GE91

Genmab
DKK 21.40-8.5%-35.9%DKK 103.0bDKK 31.80PE18.6xE20.0%n/a

GE9

Genmab
DKK 217.50-4.5%-34.6%DKK 103.0bDKK 323.16PE18.6xE20.0%n/a

GE91

Genmab
DKK 21.60-9.2%-35.7%DKK 103.0bDKK 32.09PE18.6xE20.0%n/a

AVG

Avantor
US$22.600%n/aUS$14.1bUS$29.57PE54.4xE34.8%n/a

VIA

Viatris
US$10.411.5%10.2%US$13.9bUS$11.62PB0.7xE14.4%4.2%

VIA

Viatris
US$10.32-2.2%9.4%US$13.9bUS$11.52PB0.7xE14.4%4.2%

5VA

Vaxcyte
US$100.000%n/aUS$13.8bUS$133.96PB6.9xE-1.8%n/a

5VA

Vaxcyte
US$98.50-4.4%110.5%US$13.8bUS$129.97PB7xE-1.8%n/a

RDDA

Dr. Reddy's Laboratories
₹72.504.3%16.9%₹1.1t₹71.21PE20.2xE-1.5%0.6%

BM8

BioMarin Pharmaceutical
US$62.62-1.5%-25.7%US$13.4bUS$92.92PE52.4xE30.0%n/a

SH0

Shionogi
JP¥12.30-7.7%-11.3%JP¥1.8tJP¥14.10PE12.1xE0.4%2.7%
Page 5 of 59
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.